These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32655971)

  • 1. Biomarkers and Associated Immune Mechanisms for Early Detection and Therapeutic Management of Sepsis.
    Trzeciak A; Pietropaoli AP; Kim M
    Immune Netw; 2020 Jun; 20(3):e23. PubMed ID: 32655971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 3. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of inflammation and the etiology of sepsis.
    Grondman I; Pirvu A; Riza A; Ioana M; Netea MG
    Biochem Soc Trans; 2020 Feb; 48(1):1-14. PubMed ID: 32049312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis: The evolution in definition, pathophysiology, and management.
    Gyawali B; Ramakrishna K; Dhamoon AS
    SAGE Open Med; 2019; 7():2050312119835043. PubMed ID: 30915218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis-Pathophysiology and Therapeutic Concepts.
    Jarczak D; Kluge S; Nierhaus A
    Front Med (Lausanne); 2021; 8():628302. PubMed ID: 34055825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis.
    Wang W; Yang N; Wen R; Liu CF; Zhang TN
    Front Cell Infect Microbiol; 2021; 11():563126. PubMed ID: 34055659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Recovery From Sepsis: A Review.
    Prescott HC; Angus DC
    JAMA; 2018 Jan; 319(1):62-75. PubMed ID: 29297082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.
    Horiguchi H; Loftus TJ; Hawkins RB; Raymond SL; Stortz JA; Hollen MK; Weiss BP; Miller ES; Bihorac A; Larson SD; Mohr AM; Brakenridge SC; Tsujimoto H; Ueno H; Moore FA; Moldawer LL; Efron PA;
    Front Immunol; 2018; 9():595. PubMed ID: 29670613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cytokines in sepsis and its current situation of clinical application].
    Xia ZF; Wu GS
    Zhonghua Shao Shang Za Zhi; 2019 Jan; 35(1):3-7. PubMed ID: 30678394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Point-of-Care Diagnosis of Sepsis.
    Teggert A; Datta H; Ali Z
    Micromachines (Basel); 2020 Mar; 11(3):. PubMed ID: 32164268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ Dysfunction in Sepsis: An Ominous Trajectory From Infection To Death.
    Caraballo C; Jaimes F
    Yale J Biol Med; 2019 Dec; 92(4):629-640. PubMed ID: 31866778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of pancreatic stone protein in the identification and management of sepsis.
    Eggimann P; Que YA; Rebeaud F
    Biomark Med; 2019 Feb; 13(2):135-145. PubMed ID: 30672312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
    Hattori Y; Hattori K; Suzuki T; Matsuda N
    Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis in the burn patient: a different problem than sepsis in the general population.
    Greenhalgh DG
    Burns Trauma; 2017; 5():23. PubMed ID: 28795054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cells in Sepsis and Associated Organ Dysfunction: A Promising Future or Blind Alley?
    Horák J; Nalos L; Martínková V; Beneš J; Štengl M; Matějovič M
    Stem Cells Int; 2017; 2017():7304121. PubMed ID: 29098010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis Management in Southeast Asia: A Review and Clinical Experience.
    Mehta Y; Paul R; Rabbani R; Acharya SP; Withanaarachchi UK
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus of Chinese experts on early prevention and blocking of sepsis].
    Emergency Medicine Branch Of Chinese Medical Care International Exchange Promotion Association ; Emergency Medical Branch Of Chinese Medical Association ; Chinese Medical Doctor Association Emergency Medical Branch ; Chinese People's Liberation Army Emergency Medicine Professional Committee
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):518-530. PubMed ID: 32576341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances of microfluidic technologies applied in diagnosis and treatment of sepsis].
    Yang R; Wang J; Gao Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):789-792. PubMed ID: 31315744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.